v3.26.1
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance, (in shares) at Dec. 31, 2024   37,418,470      
Beginning balance at Dec. 31, 2024 $ 234,857 $ 4 $ 457,146 $ 709 $ (223,002)
Vesting of restricted stock units   11,371      
Forfeiture of unvested common stock (in shares)   (47,363)      
Stock-based compensation expense 2,928   2,928    
Other comprehensive loss (88)     (88)  
Net loss (25,039)       (25,039)
Ending balance, (in shares) at Mar. 31, 2025   37,382,478      
Ending balance at Mar. 31, 2025 212,658 $ 4 460,074 621 (248,041)
Beginning balance, (in shares) at Dec. 31, 2024   37,418,470      
Beginning balance at Dec. 31, 2024 234,857 $ 4 457,146 709 (223,002)
Net loss (44,947)        
Ending balance, (in shares) at Jun. 30, 2025   37,533,136      
Ending balance at Jun. 30, 2025 195,831 $ 4 463,404 372 (267,949)
Beginning balance, (in shares) at Mar. 31, 2025   37,382,478      
Beginning balance at Mar. 31, 2025 212,658 $ 4 460,074 621 (248,041)
Vesting of restricted stock units   76,928      
Issuance of common stock under employee stock purchase plan (ESPP) (in shares)   75,338      
Issuance of common stock under employee stock purchase plan (ESPP) 109   109    
Forfeiture of unvested common stock (in shares)   (1,608)      
Stock-based compensation expense 3,221   3,221    
Other comprehensive loss (249)     (249)  
Net loss (19,908)       (19,908)
Ending balance, (in shares) at Jun. 30, 2025   37,533,136      
Ending balance at Jun. 30, 2025 195,831 $ 4 463,404 372 (267,949)
Beginning balance, (in shares) at Dec. 31, 2025   37,620,668      
Beginning balance at Dec. 31, 2025 158,596 $ 4 469,202 260 (310,870)
Vesting of restricted stock units   27,081      
Forfeiture of unvested common stock (in shares)   (692)      
Stock-based compensation expense 2,552   2,552    
Other comprehensive loss (304)     (304)  
Net loss (23,059)       (23,059)
Ending balance, (in shares) at Mar. 31, 2026   37,647,057      
Ending balance at Mar. 31, 2026 137,785 $ 4 471,754 (44) (333,929)
Beginning balance, (in shares) at Dec. 31, 2025   37,620,668      
Beginning balance at Dec. 31, 2025 158,596 $ 4 469,202 260 (310,870)
Net loss (50,541)        
Ending balance, (in shares) at Jun. 30, 2026   37,777,105      
Ending balance at Jun. 30, 2026 112,567 $ 4 474,096 (122) (361,411)
Beginning balance, (in shares) at Mar. 31, 2026   37,647,057      
Beginning balance at Mar. 31, 2026 137,785 $ 4 471,754 (44) (333,929)
Vesting of restricted stock units   77,543      
Issuance of common stock under employee stock purchase plan (ESPP) (in shares)   63,867      
Issuance of common stock under employee stock purchase plan (ESPP) 74   74    
Forfeiture of unvested common stock (in shares)   (11,362)      
Stock-based compensation expense 2,268   2,268    
Other comprehensive loss (78)     (78)  
Net loss (27,482)       (27,482)
Ending balance, (in shares) at Jun. 30, 2026   37,777,105      
Ending balance at Jun. 30, 2026 $ 112,567 $ 4 $ 474,096 $ (122) $ (361,411)